|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo显示文摘 | MOULDER S L YAKES F M MUTHUSWAMY S K | 2001 | Cancer Res2001，61，24： | 1 |
| 2 | 查看详情显示文摘 | YAKES F M VAN Houten B | | 0，，： | 1 |
| 3 | CM101 treatment overrides tumor-induced immunoprivilege leading to apoptosis 显示文摘 | Yakes M F Wamil B D Sun F L | 2000 | Cancer Res2000，60，： | 1 |
| 4 | PKB/Akt mediates cell -cycle pro- gression by phosphorylation of p27Kipl at threonine 157 and modula- tion of its cellular localization 显示文摘 | Shin I Yakes F M Rojo F | 2002 | Nature medicine2002，8，10： | 1 |
| 5 | Epidermal growthfactor receptor(HER1)tyrosine kinase inhibitor ZD1839(Iressa)inhibits HER2/neu(erbB-2)-overexpressing breast cancer cells invitro and in vivo显示文摘 | Moulder S L Yakes F M Muthuswamy S K | 2001 | Cancer Res2001，61，24： | 1 |
| 6 | Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo显示文摘 | Moulder S L Yakes F M Muthuswamy S K | 2001 | Cancer Res2001，61，24： | 1 |
| 7 | Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metasta- sis,angiogenesis,and tumor growth显示文摘 | Yakes F M Chen J Tan J | 2011 | Mol Cancer Ther2011，10，12： | 1 |
| 8 | Cabozantinib( XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppres- ses metastasis, angiogenesis, and tumor growth 显示文摘 | YAKES F M CHEN J TAN J | 2011 | Mol Can- cer Ther2011，10，12： | 1 |
| 9 | Paranasal sinuses on MR images of the brain: significance of mucosal thickening显示文摘 | Rak K M Newell J D 2nd Yakes W F | 1991 | AJR Am J Roentgenol1991，156，2： | 1 |
| 10 | PKB/ Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization显示文摘 | SHIN I YAKES F M ROJO F | 2002 | Nat Med2002，8，10： | 1 |
| 11 | Cabozantinib(XL184),a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth 显示文摘 | YAKES F M CHEN J TAN J | 2011 | Mol Cancer Tber2011，10，12： | 1 |
| 12 | HER (erbB) Tyrosine kinase Inhibitors in the treatment of breast cancer显示文摘 | Arteaga C Moulder S L Yakes F M | 2002 | Semin Oncol2002，29，11： | 1 |
| 13 | Tyrosine kinase inhibitors:Rationale,mechanisms of action,and implications for drug resistance显示文摘 | BUSSE D YAKES F M LENFERINK A E | 2001 | Semin Oncol2001，28，： | 1 |
| 14 | PKB/Akt mediates cell-cycle progression by phosphorylation of p27 ( Kipl ) at threonine 157 and modulation of its cellular localization 显示文摘 | SHIN I YAKES F M ROJO F | 2002 | Nat Med2002，8，10： | 1 |
| 15 | Cabozantinib(XL184), a novel Met and VEGFR2 inhibitor, simultaneously suppresses metastasis,angiogenesis,and tumor growth显示文摘 | Yakes F M Chen J Tan J | 2011 | Mol Cancer Ther2011，10，12： | 1 |
| 16 | Hercep- tin-induced inhibition of phosphatidylinositol-3 kinase and Akt is required for antibody-mediated effects on p27 ,cyclin D1 ,and an- titumor action 显示文摘 | YAKES F M CHINRATANALAB W RITIER C A | 2002 | Cancer Research2002，62，14： | 1 |
| 17 | PKB/Akt mediates cellcycle progression by phosphorylation of p27 (Kip1) at threonine 157 and modulation of its cellular localization显示文摘 | Shin I Yakes F M Rojo F | 2002 | Nat Med2002，8，10： | 1 |
| 18 | PKB/Akt mediates cell-cycle progression by phosphorylation of p27kip1 at threonine 157 and modulation of its cellular localization显示文摘 | Shin I Yakes M Rojo F | 2002 | Nature Medicine2002，8，10： | 1 |
| 19 | Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in hu- man cells following oxidative stress显示文摘 | Yakes F M Van Houten B | 1997 | Proc Natl Acad Sci US A1997，94，2： | 1 |
| 20 | Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress显示文摘 | YAKES F M HOUTEN B V | 1997 | Proceedings of the National Academy of Sciences1997，94，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员